The company has received a fund infusion of Rs 7.77 crore at the rate of Rs 72.75 per warrant.

At present, the brokerage charges incurred by mutual funds while buying and selling of shares falls outside the Total Expense Ratio (TER) that they charge unitholders.

Biden's Budget plan includes several healthcare and pharmaceutical-related proposals aimed at cutting wasteful spending and reducing costs for both the federal government and citizens. Most of these proposals will have a direct impact on the revenue of Indian pharmaceutical companies, especially the top drug makers, including Sun Pharma, Lupin, Aurobindo, Glenmark and Dr Reddy's Lab who depend on the US market for their sales and profit.

Tata Power-DDL is a joint venture between Tata Power and the Delhi government that supplies electricity to a populace of over 7 million in North Delhi.